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EVALUATION	  OF	  ASTROCYTE	  ACTION	  IN	  A	  JSK	  TREATED	  PARAQUAT	  RAT	  MODEL	  OF	  PARKINSON’S	  DISEASE	  
	  
We	  wish	  to	  extend	  our	  
hear;elt	  thanks	  to	  Mr.	  Joseph	  
Szcesei	  and	  his	  family	  for	  their	  
generous	  support	  of	  this	  
research	  
Parkinson’s	  Disease	  (PD)	  is	  the	  second	  most	  common	  neurodegenerative	  disorder,	  affecting	  7	  to	  10	  million	  
individuals	  worldwide.[1]	  This	  chronic,	  progressive	  disease	  is	  associated	  with	  the	  degeneration	  of	  
dopaminergic	  neurons	  in	  the	  substantia	  nigra	  pars	  compacta	  region	  of	  the	  basal	  ganglia.	  This	  structure	  gives	  
rise	  to	  motor,	  associative	  and	  limbic	  circuits,	  which	  incorporate	  the	  thalamus	  and	  cortices.	  [2]	  	  
	  
PD	  impacts	  all	  three	  aforementioned	  circuits	  leading	  to	  symptoms	  
such	  as	  resting	  tremors	  on	  one	  side	  of	  the	  body,	  hyopsmia	  
(reduced	  ability	  to	  smell),	  muscle	  rigidity,	  bradykinesia	  which	  is	  
slowed	  motion	  and	  a	  limited	  range	  of	  movement,	  as	  well	  as	  mood	  
and	  REM	  behaviour	  disorders.	  [1]	  	  
	  
Approximately	  90%	  of	  PD	  cases	  are	  sporadic	  [3]	  and	  oxidative	  
stress	  has	  been	  implicated	  as	  a	  key	  player	  in	  these	  situations.	  
However,	  other	  known	  and	  unknown	  factors	  are	  assumed	  to	  be	  
involved	  and	  the	  overall	  pathophysiology	  of	  the	  disease	  is	  not	  well	  
understood.	  Hence	  our	  lab	  began	  to	  consider	  the	  idea	  of	  a	  more	  
holistic	  and	  natural	  approach	  to	  treating	  PD.	  	  	  	  
	  
SUBSTANTIA	  NIGRA	  
Chinese	  culture	  has	  utilized	  natural	  herbal	  remedies	  since	  
ancient	  times	  and	  several	  concoctions	  have	  proved	  beneQicial	  for	  
treating	  illness.	  In	  2013,	  a	  novel	  herbal	  formulation	  known	  as	  	  	  	  	  
Ji-­‐Su-­‐Kang	  (JSK)	  showed	  positive	  results	  in	  healing	  damage	  due	  to	  
acute	  spinal	  cord	  injury	  (SCI)	  in	  rats,	  and	  proved	  beneQicial	  for	  a	  
few	  PD	  patients.	  [4]	  	  Therefore,	  this	  proposal	  suggests	  the	  use	  of	  JSK	  
treatment	  in	  a	  paraquat	  rat	  model	  of	  Parkinson’s	  Disease.	  	  
	  
OBJECTIVES 	   	   	   	   	   	  	  
•  Understand	  if	  JSK	  can	  provide	  neuroprotection	  
•  What	  mechanisms	  are	  employed	  by	  JSK	  if	  it	  possesses	  
neuroprotective	  activity	  
	  	   Astrocytes	  are	  the	  cells	  of	  interest	  in	  this	  project	  as	  they	  are	  
activated	  in	  response	  to	  inQlammation,	  which	  is	  a	  primal	  
immune	  response	  of	  the	  body.	  Activated	  by	  the	  lack	  of	  
neurotransmitter	  binding	  or	  the	  presence	  of	  abnormal	  
molecules,	  astrocytes	  release	  neurotrophic	  factors.	  Glial	  cell-­‐
derived	  neurotrophic	  factor	  (GDNF)	  and	  brain	  cell-­‐derived	  
neurotrophic	  factor	  (BDNF),	  are	  two	  important	  astrocyte	  
molecules	  responsible	  for	  reducing	  inQlammation	  and	  protecting	  
neurons.	  [5]	  	  
	  	  	  
Ultimately,	  the	  goal	  of	  this	  study	  is	  to	  assess	  the	  role	  of	  JSK	  in	  
astrocyte	  activation	  using	  a	  prophylactic	  paraquat	  rat	  model	  of	  
Parkinson’s	  Disease.	  	  




The	  key	  contents	  of	  the	  JSK	  
formulation:	  Ginseng,	  Chuanxiong	  
Rhi-­‐	  zoma	  (chuan	  xiong),	  Glycyrrhizae	  
Radix	  (gan	  cao),	  Paeoniae	  Alba	  Radix	  
(bai	  shao)	  and	  Cinnamomi	  Cortex	  
(rou	  gui).	  The	  Qinal	  product	  was	  
purchased	  in	  powdered	  form	  and	  
made	  into	  a	  paste.	  
•  Strawberry	  jello	  is	  used	  as	  a	  vehicle	  
to	  administer	  0.15g	  of	  JSK	  daily	  to	  
Group	  1	  
	  
•  22mL	  of	  jello	  are	  added	  to	  each	  
well	  of	  the	  icecube	  tray,	  followed	  by	  
JSK	  addition	  
	  
•  Groups	  2	  and	  3	  receive	  jello	  
without	  JSK	  supplementation	  	  
18	  male	  rats	  were	  divided	  into	  three	  groups	  and	  subjected	  to	  a	  prophylactic	  methodology.	  Prophylactic	  studies	  
aim	  to	  quantify	  the	  maximum	  neuroprotective	  capacity	  of	  the	  compounds	  of	  interest,	  by	  starting	  treatment	  prior	  
to	  inducing	  disease.	  Neurotoxin-­‐induced	  PD	  is	  commonly	  used	  in	  laboratory	  rat	  models	  and	  the	  four	  most	  
frequently	  used	  parkinsonian	  neurotoxins	  are	  6-­‐OHDA,	  MPTP,	  rotenone	  and	  paraquat	  (used	  in	  this	  study).	  	  
	  
GROUP	  1 	   	   	   	   	   	   	   	   	   	  	  
The	  Qirst	  group	  received	  regular	  jello	  (no	  JSK	  added)	  and	  saline	  injections.	  This	  group	  allowed	  any	  effects	  of	  
regular	  jello	  to	  be	  determined	  and	  functioned	  as	  a	  control	  for	  the	  stress	  of	  injections.	  	  
GROUP	  2 	   	   	   	   	   	   	   	   	   	  	  
This	  second	  group	  received	  regular	  jello	  and	  paraquat	  injections,	  acting	  as	  a	  control	  to	  assess	  maximum	  damage	  
due	  to	  the	  neurotoxin.	  
GROUP	  3 	   	   	   	   	   	   	   	   	   	  	  
The	  third	  group	  to	  which	  JSK	  supplemented	  jello	  and	  paraquat	  injections	  were	  administered,	  functioned	  as	  the	  
primary	  experimental	  group	  for	  which	  JSK	  neuroprotection	  was	  evaluated.	  
•  1	  intraperitoneal	  paraquat	  or	  
saline	  injection	  every	  5	  days	  
	  
•  Dose	  is	  10mg/kg	  
	  
•  Total	  of	  5	  injections	  are	  given	  and	  
treatment	  continues	  throughout	  







•  Treatment	  continues	  
	  
•  Rats	  are	  sacriQiced	  in	  the	  	  perfusion	  
process	  !	  brains	  obtained	  
	  



















•  Substantia	  nigra	  region	  of	  the	  
brain	  is	  sectioned	  and	  subjected	  
to	  immunohistochemistry	  
	  
•  Immunohistochemistry	  with	  anti-­‐
GFAP,	  anti-­‐BDNF,	  anti-­‐GDNF	  
antibodies	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